Metabolic syndrome (MetS) refers to a combination of risk factors such as obesity and insulin resistance that increase the likelihood of developing heart disease and diabetes. Dysbiosis in the gut microbiota plays a role in supporting metabolic well-being by influencing processes like maintaining balanced glucose levels and managing lipids and inflammation. Imbalances in populations known as dysbiosis are strongly linked to the development of metabolic syndrome–related conditions, like insulin resistance and ongoing inflammation. In this chapter, we delve into the differences in gut bacteria makeup among individuals with metabolic syndrome (MetFatsyndrome) compared to normal individuals. We highlight types of bacteria linked to obesity and metabolic issues. The idea of nutrition. Tailoring approaches based on gut bacteria composition. Is seen as a practical way to tackle metabolic syndrome. Dietary strategies like prebiotics promoting the growth of beneficial bacteria probiotics supplements and following diets such as the Mediterranean diet or high-fiber diets may have an impact on gut bacteria balance, leading to improved metabolic outcomes. Discoveries in the realm of metabolites such as short-chain fatty acids (SCFAs) and bile acids shed light on how bacteria influence human metabolic processes. This chapter also delves into treatments based on the microbiome like microbiota transplantation and genetically modified probiotics. It also discusses the challenges related to implementing precision nutrition in world settings. By utilizing microbiome-focused strategies, could revolutionize the treatment of metabolic disorders and underscore the importance of care in future healthcare practices.